×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| NGL FINE-CHEM LTD. | 1074.12 | 76.44 | 1008.58 | 12.37 | 929.0 | 44.6 |
| WANBURY LTD. | 1635.32 | 134.91 | 1631.84 | 3.95 | 906 | 21.1 |
| KOPRAN LTD. | 531.32 | 35.18 | 513.35 | 0.73 | 887 | 25.4 |
NGL Fine Chem Ltd., with Security Code 524774, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 72.9 | 69.1 | 79.4 | 84.8 | 95.6 | 88.0 | 91.4 | 86.8 | 93.0 | 100.9 |
| Expenses | 62.3 | 61.5 | 66.3 | 73.9 | 83.0 | 81.7 | 80.8 | 83.3 | 89.0 | 93.0 |
| Operating Profit | 10.6 | 7.6 | 13.1 | 11.0 | 12.6 | 6.3 | 10.6 | 3.6 | 4.0 | 7.8 |
| OPM % | 14.58% | 11% | 16.53% | 12.91% | 13.18% | 7.18% | 11.62% | 4.09% | 4.3% | 7.75% |
| Other Income | 2.7 | 3.8 | 3.8 | 4.2 | 4.2 | 6.3 | 5.4 | 0.2 | -0.8 | 6.6 |
| Interest | 0.3 | 0.2 | 0.4 | 0.3 | 0.5 | 0.4 | 0.3 | 0.6 | 0.9 | 1.2 |
| Depreciation | 1.9 | 2.0 | 2.0 | 2.1 | 2.1 | 2.1 | 2.3 | 2.3 | 2.5 | 3.4 |
| Profit before tax | 11.1 | 9.2 | 14.5 | 12.8 | 14.2 | 10.0 | 13.4 | 0.8 | -0.3 | 9.7 |
| Tax % | -23% | -14.8% | -24.4% | -30.5% | -23.8% | -21.8% | -25.2% | -3.5% | 0% | 21.3% |
| Net Profit | 8.5 | 7.8 | 11.0 | 8.9 | 10.8 | 7.8 | 10.0 | 0.8 | -0.5 | 7.6 |
| EPS in Rs | 13.81 | 12.63 | 17.76 | 14.4 | 17.56 | 12.67 | 16.26 | 1.27 | 0 | 12.37 |
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 71.9 | 73.9 | 71.0 | 80.2 | 88.0 | 99.8 | 90.8 | 93.5 | 89.1 | 95.0 |
| Expenses | 62.1 | 60.9 | 61.2 | 66.2 | 74.1 | 83.9 | 81.4 | 81.9 | 84.0 | 88.6 |
| Operating Profit | 9.8 | 13.0 | 9.9 | 14.0 | 13.9 | 15.8 | 9.4 | 11.6 | 5.1 | 6.4 |
| OPM % | 13.64% | 17.56% | 13.88% | 17.42% | 15.77% | 15.86% | 10.3% | 12.36% | 5.72% | 6.7% |
| Other Income | 0.7 | 2.1 | 3.3 | 3.2 | 3.7 | 3.7 | 5.9 | 5.1 | -0.1 | -1.0 |
| Interest | 0.3 | 0.3 | 0.2 | 0.4 | 0.3 | 0.5 | 0.4 | 0.3 | 0.6 | 1.0 |
| Depreciation | 1.2 | 2.7 | 2.9 | 2.9 | 2.9 | 2.9 | 3.0 | 3.0 | 3.1 | 3.3 |
| Profit before tax | 9.0 | 12.1 | 10.1 | 13.9 | 14.3 | 16.1 | 11.8 | 13.3 | 1.3 | 1.1 |
| Tax % | -28% | -22.6% | -15.6% | -24.8% | -30% | -23.4% | 21.8% | 26.4% | -0.9% | -47.2% |
| Net Profit | 6.5 | 9.3 | 8.5 | 10.5 | 10.0 | 12.3 | 9.2 | 9.8 | 1.3 | 0.5 |
| EPS in Rs | 10.5 | 15.09 | 13.77 | 16.96 | 16.24 | 19.95 | 14.92 | 15.88 | 2.07 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 19% |
| 3 Years: | 4% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 8% |
| 3 Years: | -30% |
| TTM: | -53% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 29% |
| 3 Years: | -12% |
| 1 Year: | -44% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 19% |
| 3 Years: | 5% |
| TTM: | 9% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 17% |
| 3 Years: | -25% |
| TTM: | -49% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 29% |
| 3 Years: | -12% |
| 1 Year: | -44% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|